A61K

Drug Preparations & Formulations

EPO Patent Bulletin

← All categories
Filter: All Amended Grant Correction Grant Limitation Publication Search Report

57 items

(filtered)
Publication

Retargeted Retroviral Vectors Resistant To Vaccine Induced Neutralization And Compositions Or Methods Of Use Thereof

EP4433579A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Relaxin 2 Fusion Protein Analogs And Methods Of Using Same

EP4429694A2 · Tectonic Operating Company, Inc. · Mar 18, 2026
Publication

Recombinant Newcastle Disease Virus Expressing Spike Protein Of Sars Cov 2 Delta Variant And Uses Thereof

EP4408463A2 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Compositions For Use In Treatment Of Type Vii Collagen Deficiencies

EP4245314A2 · Innovator 21, LLC · Mar 18, 2026
Publication

Bisphosphocin Gel Formulations And Uses Thereof

EP4241769A2 · Lakewood Amedex, Inc. · Mar 18, 2026
Publication

Use Of Anti Il 1 Beta Antibodies

EP4218815A2 · Novartis AG · Mar 18, 2026
Publication

Antibodies For The Treatment And Prevention Of Covid 19 And Emerging Variants

EP4330279A2 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Engineering B Cell Based Protein Factories To Treat Serious Diseases

EP4326290A2 · Walking Fish Therapeutics, Inc. · Mar 18, 2026
Publication

Bifunctional Molecules For Selective Modification Of Target Substrates

EP4320126A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Anti Inflammatory Siglec Proteins And Methods Of Making And Using Same

EP4323378A2 · Palleon Pharmaceuticals Inc. · Mar 18, 2026
Publication

Heteroaryl Derivatives As Pd1/Pd L1 Inhibitors For The Treatment Of Hbv And Cancer

EP4313968A2 · Arbutus Biopharma Corporation · Mar 18, 2026
Publication

Engineered Antimicrobial Peptides And Usage Thereof

EP4337321A2 · University of Pittsburgh - of the Commonwealth System of Higher Education · Mar 18, 2026
Publication

Indications For Anti Prame Binders

EP4412642A2 · immatics biotechnologies GmbH · Mar 18, 2026
Publication

Epigenetic Gene Regulation To Treat Neurological Diseases And Pain

EP4284927A2 · Navega Therapeutics, Inc. · Mar 18, 2026
Publication

Platelet Alpha Granules For Delivery Of Multiple Proteins

EP4284917A2 · Longitude Therapeutics S.r.l. · Mar 18, 2026
Publication

Artemisinin Proteasome Inhibitor Conjugates And Their Use In The Treatment Of Disease

EP4281066A2 · Cornell University · Mar 18, 2026
Publication

Compositions And Methods For Enhancing Anti Viral Therapies

EP4301355A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Cyclic Peptide Immunomodulators

EP4323380A2 · Bristol-Myers Squibb Company · Mar 18, 2026
Publication

Aav8 Capsid Variants With Enhanced Liver Targeting

EP4330270A2 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Heterocyclic Compounds As Ret Kinase Inhibitors

EP4104837A2 · Cancer Research Technology Limited · Mar 18, 2026
Publication

Products And Compositions

EP4219713A2 · Silence Therapeutics GmbH · Mar 18, 2026
Publication

Rho Kinase Inhibitors

EP4116293A2 · Kadmon Corporation, LLC · Mar 18, 2026
Publication

Tnf Alpha And Ngf Antibodies For Veterinary Use

EP4263603A2 · Elanco US Inc. · Mar 18, 2026
Publication

Engineered Crispr Cas Systems And Methods For Sensitive And Specific Diagnostics

EP4143307A2 · Montana State University · Mar 18, 2026
Publication

Recombinant Sars Cov 2 Spike Protein Subunits, Expression And Uses Thereof

EP4208198A2 · Hawaii Biotech, Inc. · Mar 18, 2026
Publication

Methods And Treatment Involving Excess Free Light

EP4126945A2 · Avalo Therapeutics, Inc. · Mar 18, 2026
Publication

Treatment Of Inflammatory Diseases With Peptides And Pharmaceutical Compositions

EP4114430A2 · YUYU Pharma, Inc. · Mar 18, 2026
Publication

Increased Solubilization Of Ethylhexyl Triazone

EP4259074A2 · TotalEnergies OneTech · Mar 18, 2026
Publication

Vaccine Against Human Pathogenic Coronaviruses

EP4138899A2 · ACM Biolabs Pte Ltd · Mar 18, 2026
Publication

Bicyclic Kinase Inhibitors And Uses Thereof

EP4143191A2 · iOmx Therapeutics AG · Mar 18, 2026
Publication

Immunoassay Of S Adenosylmethionine Using Analogs Thereof And Personalized Therapeutics

EP3915584A2 · Hao, Xiujuan · Mar 18, 2026
Publication

Molecules With Altered Neonate Fc Receptor Binding Having Enhanced Therapeutic And Diagnostic Properties

EP3888690A2 · MedImmune, LLC · Mar 18, 2026
Publication

Chimeric Proteins For Selective Lysis Of Bacteria

EP4051243A2 · Bactoclear Holdings Pte. Ltd. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4076524A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Histone Deacytlase 6 Modulation Of Titin Protein Mediated Cardiac Tissue Stiffness And Method For Same

EP4069364A2 · The Regents of the University of Colorado, a body corporate · Mar 18, 2026
Publication

A Method Of Altering A Differentiation Status Of A Cell

EP3953452A2 · Agency for Science, Technology and Research · Mar 18, 2026
Publication

Hydrogels And Methods Of Using The Same

EP3937941A2 · The Regents of the University of California · Mar 18, 2026
Publication

Methods For Expansion Of Natural Killer (Nk) Cell Subset And Related Compositions And Methods

EP3884041A2 · Indapta Therapeutics, Inc. · Mar 18, 2026
Publication

Mycobacterial Antigen Compositions And Methods Of Use

EP3784275A2 · Children's National Medical Center · Mar 18, 2026
Publication

Fusion Protein Constructs For Complement Associated Disease

EP3893916A2 · Akebia Therapeutics, Inc. · Mar 18, 2026
Publication

Hydroxynorketamine For The Use In The Treatment Of Depression

EP3641742A2 · Ketabon GmbH · Mar 18, 2026
Publication

Compositions For Prolonging The Survival After Orthopic And Heteropic Xenogeneic Heart, Kidney, Lung Or Liver Transplantations

EP3773570A2 · Reichart, Bruno · Mar 18, 2026
Publication

C5 Ar Inhibitors For Use In The Treatment Of Chemotherapy Induced Iatrogenic Pain

EP3723744A2 · Dompé farmaceutici S.p.A. · Mar 18, 2026
Publication

Igf 1 R Monoclonal Antibodies And Uses Thereof

EP3638320A2 · Centre for Probe Development and Commercialization · Mar 18, 2026
Publication

Compositions And Methods For Treating Pain Disorders

EP3610019A2 · Mansell, John · Mar 18, 2026
Publication

Biologic For The Treatment Of Cancer

EP3606548A2 · Loma Linda University · Mar 18, 2026
Publication

Compositions For The Treatment Of Disease

EP3448987A2 · Voyager Therapeutics, Inc. · Mar 18, 2026
Publication

Anti Human Vista Antibodies And Use Thereof

EP3442579A2 · Immunext, Inc. · Mar 18, 2026
Publication

Methods Of Treatment Using Chlorotoxin Conjugates

EP3442996A2 · Blaze Bioscience, Inc. · Mar 18, 2026
Publication

Plectin 1 Binding Antibodies And Uses Thereof

EP3439692A2 · ZIELBIO, INC. · Mar 18, 2026
Publication

Chimeric Antigen Receptors Targeting Cancer

EP3436070A2 · University of Southern California · Mar 18, 2026
Publication

Calcium Peroxide Nanoparticles As Adjuvant Therapy

EP3618874A2 · University Of Ulster · Mar 18, 2026
Publication

Inhibitors Of Cytochrome P450 Family 7 Subfamily B Member 1 (Cyp7 B1) For Use In Treating Diseases

EP3558304A2 · Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) · Mar 18, 2026
Publication

Ebola Virus Antibodies And Binding Agents Derived Therefrom

EP3487521A2 · Emory University · Mar 18, 2026
Publication

Commercially Viable Synthesis Of Cantharidin And Bioactive Cantharidin Derivatives

EP3233865A2 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Optimised Subcutaneous Therapeutic Agents

EP2838566A2 · Cantab Biopharmaceuticals Patents Limited · Mar 18, 2026
Publication

Bispecific Antibodies Against Her2 And Cd3

EP2699262A2 · Genmab A/S · Mar 18, 2026